ArticleCroatian medical journal2022
Senhance robot-assisted adrenalectomy: a case series.
Article in Croatian medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- New Robotic Platforms in General Surgery: What's the Current Clinical Scenario?Medicina (Kaunas, Lithuania) · 2023Pooled it
- Systematic Review and Clinical Outcomes of new Robotic Systems in Urology.International braz j urol : official journal of the Brazilian Society of UrologyPooled it
- Oncological outcomes after Senhance robot-assisted radical prostatectomy: biochemical recurrence and risk stratification in a large single-centre cohort.Journal of robotic surgery · 2026Article
- Robotic adrenalectomy: comparison of DaVinci, HUGO™-RAS and VersiusUpdates in surgery · 2026Article
- Article
- Robotic adrenalectomy: a comprehensive review of perioperative outcomes, comparative efficacy, and technological advancements.Journal of robotic surgery · 2025Review
- Article
- Initial experience with the Carina™ platform in robotic-assisted hysterectomy for gynecological malignant disease.Surgical endoscopy · 2025Article
- Perioperative, Oncological, and Functional Outcomes of New Multiport Robotic Platforms in Urology: A Systematic Review and Meta-analysis.European urology open science · 2025Review
- Article
- Evaluation of Clinical Research on Novel Multiport Robotic Platforms for Urological Surgery According to the IDEAL Framework: A Systematic Review of the Literature.European urology open science · 2024Review
- Utility of a 3 mm Bipolar Instrument in Laparoscopic Renal Surgery Using the Senhance Robotic System.Cureus · 2024Article
- Comparison of robotic and laparoscopic lateral transperitoneal adrenalectomies.Annals of surgical treatment and research · 2023Article
- Comparative Analysis of Laparoscopic and Robotic Transperitoneal Adrenalectomy Performed at a Single Institution.Medicina (Kaunas, Lithuania) · 2022Article
- New multiport robotic surgical systems: a comprehensive literature review of clinical outcomes in urology.Therapeutic advances in urologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present a case series of 12 consecutive robot-assisted adrenalectomies performed from May 2019 to March 2020 by a single surgeon experienced in laparoscopy using the novel Senhance robotic system. Eleven patients had primary aldosteronism due to an adrenal adenoma, diagnosed by means of endocrinological and radiological evaluation, and 1 had a benign adrenal cyst. The robotic adrenalectomy technique is described in detail. The mean procedure time was 165.1 minutes, with robotic docking time of 11.6 minutes and console time of 98.6 minutes. The mean estimated blood loss was 47 mL, and hospital stay duration was 4.5 days. There was 1 Clavien Dindo IIIB complication and 1 patient underwent conversion to laparoscopy. All patients with adenoma had complete biochemical remission after surgery. In conclusion, the Senhance robotic system is a safe and feasible platform for benign adrenal surgery in high-volume centers.
Indexed as
Identifiers
35505653PMC9086822What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.